This week we look at an artificial intelligence-powered platform that can detect early signs of heart disease, the Food and Drug Administration’s treatment clearance that could help prevent migraine symptoms, and a revolutionary genomic medicine startup that raised $135 million. We also highlight researchers who created a soft 3D-model of a heart. And finally, we look at research that shows promise for stroke victims with mobility issues.
Each week we highlight five things affecting the life sciences industry. Here’s the latest.
Cardio Diagnostics Holdings Inc announced the launch of their epigenetic blood test known as PrecisionCHD. Their machine-learning model was developed by analyzing billions of genomic and epigenomic data points and can detect coronary heart disease with better than 75% sensitivity in both men and women. The company plans to expand the platform over the next two years and further improve their ability to detect and assist in the treatment of cardiovascular disease.
The FDA has expanded their clearance of the Nerivio device to include prevention of migraine symptoms. Nerivio is the first FDA- cleared and drug-free wearable device that can be used for both the prevention and treatment of migraine symptoms. The device gained national recognition in November 2019 after it was named to TIME Magazine’s annual list of top 100 best inventions.
Chroma Medicine is hoping to pioneer a new class of single-dose genomic medicines that harness epigenetics to revolutionize the treatment of disease. Despite a difficult macroeconomic environment, the company has successfully raised $135 million to help build out their platform.
Researchers at MIT have created a process to develop a 3D replica of a patient’s heart. The team uses cardiovascular data from the patient to print a customized soft model. Since all hearts are different, demonstrating the ability to create a customized robotic heart that can re-create the form and function of a patient’s heart is the first step to improving the future applicability and success of 3D-printed hearts.
Researchers from the University of Pittsburgh and Carnegie Mellon University found that spinal cord stimulation provided instant improvement of arm and hand mobility for stroke victims. The latest study was published in Nature Medicine and shows promise for helping stroke victims regain their mobility.